154 related articles for article (PubMed ID: 1700754)
61. On the mechanism of human T cell suppression.
Salgame P; Modlin R; Bloom BR
Int Immunol; 1989; 1(2):121-9. PubMed ID: 2535060
[TBL] [Abstract][Full Text] [Related]
62. Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.
Chaduvula M; Murtaza A; Misra N; Narayan NP; Ramesh V; Prasad HK; Rani R; Chinnadurai RK; Nath I
Infect Immun; 2012 Feb; 80(2):742-52. PubMed ID: 22144494
[TBL] [Abstract][Full Text] [Related]
63. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
Sasiain MD; de la Barrera S; Valdez R; Balina LM
Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
[TBL] [Abstract][Full Text] [Related]
64. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.
Gill HK; Ridley DS; Ganesan J; Mustafa AS; Rees RJ; Godal T
Lepr Rev; 1990 Mar; 61(1):25-31. PubMed ID: 2181222
[TBL] [Abstract][Full Text] [Related]
65. Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.
Stoner GL; Mshana RN; Touw J; Belehu A
Scand J Immunol; 1982 Jan; 15(1):33-48. PubMed ID: 6176016
[TBL] [Abstract][Full Text] [Related]
66. Human T cell recognition of the Mycobacterium leprae LSR antigen: epitopes and HLA restriction.
Oftung F; Lundin KE; Meloen R; Mustafa AS
FEMS Immunol Med Microbiol; 1999 Jun; 24(2):151-9. PubMed ID: 10378414
[TBL] [Abstract][Full Text] [Related]
67. Genetic control of immunopathology induced by Mycobacterium leprae.
de Vries RR
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):12-6. PubMed ID: 1904200
[TBL] [Abstract][Full Text] [Related]
68. Phenotypic and functional characterization of human suppressor T-cell clones: II. Activation by Mycobacterium leprae presented by HLA-DR molecules to alpha beta T-cell receptors.
Li SG; Elferink DG; de Vries RR
Hum Immunol; 1990 May; 28(1):11-26. PubMed ID: 1692823
[TBL] [Abstract][Full Text] [Related]
69. Immunoreactivity of T-cells from leprosy patients to ICRC and M. leprae antigens before and after vaccination.
Gangal SG; Chiplunkar SV; Shinde SR; Samson PD; Deo MG
Trop Med Parasitol; 1990 Sep; 41(3):314-6. PubMed ID: 1701562
[No Abstract] [Full Text] [Related]
70. A comparative study on the effects of rIL-4, rIL-2, rIFN-gamma, and rTNF-alpha on specific T-cell non-responsiveness to mycobacterial antigens in lepromatous leprosy patients in vitro.
Ottenhoff TH; Wondimu A; Reddy NN
Scand J Immunol; 1990 May; 31(5):553-65. PubMed ID: 2111939
[TBL] [Abstract][Full Text] [Related]
71. The human CD1-restricted T cell repertoire is limited to cross-reactive antigens: implications for host responses against immunologically related pathogens.
Sieling PA; Torrelles JB; Stenger S; Chung W; Burdick AE; Rea TH; Brennan PJ; Belisle JT; Porcelli SA; Modlin RL
J Immunol; 2005 Mar; 174(5):2637-44. PubMed ID: 15728470
[TBL] [Abstract][Full Text] [Related]
72. HLA-DQ-controlled T cell response to soluble egg antigen of Schistosoma japonicum in humans.
Ohta N; Edahiro T; Ishii A; Yasukawa M; Hosaka Y
Clin Exp Immunol; 1990 Mar; 79(3):403-8. PubMed ID: 2317945
[TBL] [Abstract][Full Text] [Related]
73. T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy.
Ohyama H; Matsushita S; Nishimura F; Kato N; Hatano K; Takashiba S; Murayama Y
Vaccine; 2001 Nov; 20(3-4):475-82. PubMed ID: 11672912
[TBL] [Abstract][Full Text] [Related]
74. The classical and alternate pathways of T cell activation are impaired in leprosy.
Muthukkaruppan V; Chakkalath HR; Malarkannan S
Immunol Lett; 1988 Sep; 19(1):55-8. PubMed ID: 2903849
[TBL] [Abstract][Full Text] [Related]
75. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells.
Watanabe H; Okumura M; Hirayama K; Sasazuki T
Tissue Antigens; 1990 Aug; 36(2):69-74. PubMed ID: 1702907
[TBL] [Abstract][Full Text] [Related]
76. In-vitro lymphoproliferative response to Mycobacterium leprae of HLA-D-identical siblings of lepromatous leprosy patients.
Stoner GL; Touw J; Belehu A; Naafs B
Lancet; 1978 Sep; 2(8089):543-7. PubMed ID: 79915
[TBL] [Abstract][Full Text] [Related]
77. Human immune response to recombinant interferon gamma and protein antigen LSR2.
Nath I; Laal S; Sivasai KS; Tangri S; Murtaza A; Singh S; Wilfred D; Misra RS
Trop Med Parasitol; 1990 Sep; 41(3):324-5. PubMed ID: 1701565
[No Abstract] [Full Text] [Related]
78. Thalidomide does not perturb CD2, CD4, CD5, CD8, HLA-DR, or HLA-A, B, C molecules in vitro on the membranes of cells with immune potential.
Shannon EJ; Howe RC; McLean K; Hastings RC
Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):717-29. PubMed ID: 7876469
[TBL] [Abstract][Full Text] [Related]
79. Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide.
Molloy A; Gaudernack G; Levis WR; Cohn ZA; Kaplan G
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):973-7. PubMed ID: 1689064
[TBL] [Abstract][Full Text] [Related]
80. Schwann cells are able to present exogenous mycobacterial hsp70 to antigen-specific T lymphocytes.
Ford AL; Britton WJ; Armati PJ
J Neuroimmunol; 1993 Mar; 43(1-2):151-9. PubMed ID: 7681446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
